Library

Global Action Plan to Prevent & Control NCDs

Noncommunicable diseases (NCDs) – mainly cardiovascular diseases, cancers, chronic respiratory diseases and diabetes – are the biggest cause of death worldwide. More than 36 million die annually from NCDs (63{ddf8d179d1bf712bb2a88ff2ad95ebdf63eaa5463c845d2f093b25848387ba96} of global deaths), including 14 million people who die too young before the age of 70. More than 90{ddf8d179d1bf712bb2a88ff2ad95ebdf63eaa5463c845d2f093b25848387ba96} of these premature deaths from NCDs […]

Global Action Plan to Prevent & Control NCDs Read More »

10 facts on physical activity

A lack of physical activity is a significant risk factor for noncommunicable diseases (NCDs) such as stroke, diabetes, and cancer. Less and less physical activity is occurring in many countries – globally, 23{ddf8d179d1bf712bb2a88ff2ad95ebdf63eaa5463c845d2f093b25848387ba96} of adults and 81{ddf8d179d1bf712bb2a88ff2ad95ebdf63eaa5463c845d2f093b25848387ba96} school-going adolescents are not active enough. WHO have identified 10 facts about physical activity, including: it reduces the

10 facts on physical activity Read More »

The cost of unsafe care

Given the growing importance of patient safety for both health systems and patients, it is necessary to assess the impact of patient safety efforts and to develop priorities for action. In addition to increased cost of healthcare services, unsafe care also leads to loss of trust in health care systems by the public and diminished

The cost of unsafe care Read More »

Public consultation on AMR

The European Commission will be launching a ‘One Health’ action plan to support Member States in the fight against antimicrobial resistance  and is currently asking for the views and input of citizens, administrations, associations and other organisations. Respondents are invited to take part in the consultation by completing an online questionnaire, either the one for

Public consultation on AMR Read More »

New approach needed to tackle rising drug prices

The proliferation of high-cost medicines and rising drug prices are increasing pressures on public health spending and calling into question the pharmaceutical industry’s pricing strategies. According to a new report from the OECD, ‘ New Health Technologies: Managing Access, Value and Sustainability’, pharmaceutical spending is increasingly skewed towards high-cost products. The launch prices of drugs

New approach needed to tackle rising drug prices Read More »

Scroll to Top